Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-011040
Filing Date
2017-05-15
Accepted
2017-05-15 16:20:45
Documents
82
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q isco-10q_20170331.htm 10-Q 2022725
2 EX-10.2 isco-ex102_184.htm EX-10.2 33582
3 EX-31.1 isco-ex311_8.htm EX-31.1 8993
4 EX-31.2 isco-ex312_9.htm EX-31.2 9327
5 EX-32.1 isco-ex321_7.htm EX-32.1 5526
6 EX-32.2 isco-ex322_6.htm EX-32.2 6226
  Complete submission text file 0001564590-17-011040.txt   9138539

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT isco-20170331.xml EX-101.INS 2133906
8 XBRL TAXONOMY EXTENSION SCHEMA isco-20170331.xsd EX-101.SCH 69285
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE isco-20170331_cal.xml EX-101.CAL 43853
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isco-20170331_def.xml EX-101.DEF 331038
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE isco-20170331_lab.xml EX-101.LAB 476579
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isco-20170331_pre.xml EX-101.PRE 463286
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

EIN.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51891 | Film No.: 17844495
SIC: 2834 Pharmaceutical Preparations